Office of the President

The President of the College, Prof. Emmanuel Asante is the Chief Executive Officer of the College responsible for organising and conducting the academic, financial, and administrative business of the College.

He is an Adjunct Professor University of Ghana and a Senior Lecturer at the University College London (UCL). He is also an MRC Band 2B Senior Scientist with PHD in Biomechemical Genetics from the University of Edinburgh, Edinburgh (1985-1988).

Prof. Emmanuel A. Asante


Role of the President

He shall have overall authority over the academic, financial and administrative staff and shall submit annually, through the Academic Board of Council, a statement of the staff which, in his opinion, is necessary for the transaction of College business.

The President shall, subject to approval of Council, have power to delegate any of the functions assigned him by Council to any Senior Member of the College as shall seem to him appropriate.

Educational Qualification

1979-1982 BSc (Hons) (2.1) Animal Science, University of Ghana, Legon, Ghana

1984-1985 MSc Animal Genetics, Institute of Animal Genetics, University of Edinburgh, (wrote and passed qualifying MSc examination before transferring registration to start PhD).

1985-1988 PhD* Biochemical Genetics, University of Edinburgh, Edinburgh.

Professional History

1982-1984 Research Assistant, University of Ghana, Legon, Ghana.

1988-1991 Higher Scientific Officer, The Roslin Institute, Edinburgh.

1991-1994 Postdoctoral Research Fellow, Royal Veterinary College, London.

1994-2002 Research Associate, Imperial College School of Medicine at St. Mary’s, London.

2002-2014 Band 3 Senior Scientist, MRC Prion Unit, UCL Institute of Neurology, London.

2014-2017 Band 2A Senior Scientist, MRC Prion Unit, UCL Institute of Neurology, London.

2016-present Senior Lecturer, University College London (UCL)

2017-present Band 2B Senior Scientist, MRC Prion Unit at UCL, Institute of Prion Diseases, London.


Asante, E. A., Smidak, M., Grimshaw, A., Houghton, R., Tomlinson, A., Jeelani, A., . . . Collinge, J. (2015). A naturally occurring variant of the human prion protein completely prevents prion disease. Nature, 522(7557), 478-481. doi:10.1038/nature14510

Asante, E. A., Grimshaw, A., Smidak, M., Jakubcova, T., Tomlinson, A., Jeelani, A., . . . Collinge, J. (2015). Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS. PLoS Pathog, 11(7), e1004953. doi:10.1371/journal.ppat.1004953

Clayton, E. L., Mizielinska, S., Edgar, J. R., Nielsen, T. T., Marshall, S., Norona, F. E., Asante, E.A., Collinge, J., The FReJA consortium, Isaacs, A. M. (2015). Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology. Acta Neuropathologica. doi:10.1007/s00401-015-1475-3

Asante, E. A., Linehan, J. M., Smidak, M., Tomlinson, A., Grimshaw, A., Jeelani, A., . . . Collinge, J. (2013). Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion protein. PLoS Pathog, 9(9), e1003643. doi:10.1371/journal.ppat.1003643

Asante, E. A., Gowland, I., Grimshaw, A., Linehan, J. M., Smidak, M., Houghton, R., Osiguwa O, Tomlinson A, Joiner S, Brandner S, Wadsworth JDF, Collinge J. (2009). Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J GEN VIROL, 90, 546-558. doi:10.1099/vir.0.007930-0

Pin It on Pinterest

Share This